LIRAGLUTIDE AND ORLISTAT TREATMENT FOR PERSISTENT TYPE 2 DIABETES AFTER GASTRIC BANDING: A PILOT STUDY
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Liraglutide (Primary) ; Orlistat (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Jan 2018 Status changed from recruiting to discontinued.
- 10 Jun 2017 Biomarkers information updated
- 13 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.